Summary

Results from the Aldosterone Receptor Blockade in Diastolic Heart Failure [Aldo-DHF; ISCRTN94726526] trial showed that spironolactone significantly improves diastolic function and blood pressure control, but not exercise capacity, in patients with diastolic heart failure.

  • Heart Failure
  • Hypertensive Disease
  • Cardiology Clinical Trials
View Full Text